Good MorningEquity markets cheered the FOMC's latest policy shift but should not be sanguine. The Fed's shift is likely short-lived, given the impact of the news on oil and equity markets. The Fed signaled at least three quarter-point interest rate cuts in 2024, clearing the runway for oil and risk-on asset demand. In this environment, inflation could easily accelerate, leading the FOMC to revert to its tighter stance.
The S&P 500 gained more than 1.25% at the height of the session as investors loaded up on deep-value stocks with high yields and a significant chance of outperforming bonds as interest rates fall. Capital invested in such names will continue to pay the same 4% to 6% yield as bonds indefinitely, with the added bonus of capital appreciation.
The bad news is that the technical outlook for the S&P 500 continues to deteriorate. The market moved higher with a solid gain but indicators such as MACD and stochastic are overbought and diverging from the action suggesting growing weakness as the rally grinds higher.
Featured: Most Effective Investment Strategy On Earth (Investing Daily) 
|
Stocks | | |
Mastering the art of selecting the right dividend stocks is a top skill set among investors seeking financial prosperity. Learning how to research and find the best dividend-paying stocks becomes crucial as you search for the highest yield stock dividends.
Investing in stocks offering a goo... Read the Full Story |
|
From Our PartnersAfter a rough outing in 2022, 2023 has been explosive.
In fact, since the year began, major indices, like the S&P 500 are up about 15% year to date. Heading into New Year 2024, things could get even better.
That said, here are three "no brainer" stocks to consider.
| | Click Here to Download the FREE Report |
|
Stocks | | |
Dividends are commonly thought of as a reward for long-term investors. Every quarter, certain public companies pay out dividends to their shareholders, who can then use them as income or reinvest them back into the company. But, since company stock only needs to be held for a day for dividend elig... Read the Full Story |
|
Markets | | |
Are you looking for a dividend investing strategy that can help you generate income and grow your portfolio over time? If you are like many investors, you understand the importance of finding top-rated dividend stocks that can provide steady and reliable returns. But with so many options out there... Read the Full Story |
|
From Our PartnersAccording to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy.
Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech." | | | | See why investors are taking a hard look at vanadium right now. |
|
Markets | | |
Being a successful investor takes a lot of discipline, which is genuinely one of the deepest endeavors anyone can take on. Assuming you are not the average investor (you are here, so it's a safe assumption), you understand that a story without numbers is a fairytale and numbers without a story are... Read the Full Story |
|
Markets | | | It's been a great year for stock markets around the world.Wall Street's rally has been front and center, with the U.S. stock market the world's largest and its clear leader in performance in recent years. The S&P 500 is on track to return more than 20% for the third time in the last five years, ... Read the Full Story |
|
From Our PartnersAfter the massive market collapse and several huge scandals last year, a lot of experts are saying the crypto markets are just one more step away from going to zero. But are they right? | | | | Click here to hear him explain why. |
|
Markets | | |
The S&P 500 (NYSE: SPY) is up for the year, but it’s been a tough grind for most. While the broad market is up more than 20% year-to-date, the gains are centered in only two sectors and not all the stocks in those sectors are performing as well. Nine of the eleven sectors are down for th... Read the Full Story |
|
Markets | | | The Bank of England kept borrowing rates unchanged Thursday despite mounting worries over the state of the British economy, and it showed little sign that it is contemplating cutting them anytime soon — unlike the U.S. Federal Reserve.The central bank left its main interest rate at a 15-year high of... Read the Full Story |
|
Markets | | | Pfizer heads into 2024 with a lower-than-expected sales forecast for its COVID-19 vaccine and treatment after weaker demand had already forced it to trim 2023 projections.The drugmaker announced on Wednesday initial expectations for the new year that include about $8 billion in combined sales from i... Read the Full Story |
|
Markets | | | The Bank of Japan’s quarterly survey on business sentiment shows large Japanese manufacturers have grown more optimistic in the past several months, the third straight quarter of improvement even while other data showed the economy in a contraction. The central bank's “tankan” survey, released Wedne... Read the Full Story |
|
Markets | | | The European Central Bank kept its key interest rate at a record high Thursday and said it will leave it there as long as needed to battle back inflation, signaling that cuts are not around the corner despite expectations it will act next year to support the shrinking economy.It follows similar deci... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Qualigen Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California. | | View Today's Stock Pick |
|
